Garlic has a long history in traditional medicine, but evidence for its benefits varies by preparation, and patients taking medications that increase bleeding risk should use it with caution.
|Articles|April 13, 2015
2015 Pharmacist Salary Guide
Learn what other pharmacists are making across multiple niches in pharmacy.
Advertisement
There is a plethora of relevant data on current pharmacist salaries, so we've boiled it down for you.
Learn what other pharmacists are making across multiple niches in pharmacy.
Click the image to download as a PDF:
Sources
- http://www.pharmacyschoolhq.org/pharmacist-salary-guide/
- http://www.pharmacyweek.com/cm/salary_survey
- http://www.bls.gov/ooh/healthcare/pharmacists.htm
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930253/
- http://drugtopics.modernmedicine.com/drug-topics/news/drug-topics-2015-salary-survey-pharmacist-incomes-hold-steady?page=full
- http://www.aacp.org/resources/research/institutionalresearch/Pages/salarydata.aspx
- http://money.usnews.com/careers/best-jobs/pharmacist/salary
Advertisement
Related to this article
About 89% of Americans live within 5 miles of a pharmacy, but proximity says little about whether they can afford their medications or get real counseling.
The costs to patients, their families, their workplaces, and their communities go well beyond dollars and cents.
Getting patients vaccinated matters more than which COVID-19 vaccine they receive, says Jodi Longueil, PharmD.
The new agreement lets Hims & Hers patients obtain FDA-approved tirzepatide and orforglipron at Lilly’s self-pay prices.
The approval is supported by findings from the phase 3 OCEANIC-STROKE trial.
Pharmacists can plan career sabbaticals before retirement with smart savings, employer leave options, and intentional steps that balance their finances with their goals.
Christie Ballantyne, MD, explains how the CORALreef Extension study adds safety exposure and shows LDL-C lowering with oral enlicitide is sustained over time.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Oral PCSK9 Inhibitor Enlicitide Sustains LDL-C Reductions
2
FDA Requires Class-Wide GLP-1 RA Labeling Changes for Potential NAION Risk
3
FDA Approves Pimicotinib for Tenosynovial Giant Cell Tumor
4
Lilly–Hims & Hers GLP-1 Deal Tests Whether Convenience Can Deliver Continuity of Care
5